About this trial
Phase 1 trial
Patient Profile
Paediatric CD22 positive acute lymphocytic leukemia (ALL).
Where’s this trial being run?
Crumlin Children’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | ITCC 059 |
|---|---|
| Number: | 18-16 |
| Full Title: | A Phase 1 study of Inotuzumab Ozogamycin as a single agent and in combination with chemotherapy for paediatric CD22-Positive ALL |
| Principal Investigator: | Dr Owen Smith |
|---|---|
| Type: | Collaborative |
| Sponsor: | Erasmus Medical Centre |
| Recruitment Started: |
Global: Not Available Ireland: Not Available |
| Global Recruitment Target: | Not Available |
|---|---|
| Ireland Recruitment Target: | Not Available |